[文献资料]参 考 文 献

Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations .A randomized phase Ⅱ study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung can ......